TY - JOUR
T1 - Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
AU - Jørgensen, Anders Berg
AU - Frikke-Schmidt, Ruth
AU - West, Anders Sode
AU - Grande, Peer
AU - Nordestgaard, Børge G
AU - Tybjærg-Hansen, Anne
PY - 2013
Y1 - 2013
N2 - AimsElevated non-fasting triglycerides mark elevated levels of remnant cholesterol. Using a Mendelian randomization approach, we tested whether genetically increased remnant cholesterol in hypertriglyceridaemia due to genetic variation in the apolipoprotein A5 gene (APOA5) associates with an increased risk of myocardial infarction (MI).Methods and resultsWe resequenced the core promoter and coding regions of APOA5 in individuals with the lowest 1% (n = 95) and highest 2% (n = 190) triglyceride levels in the Copenhagen City Heart Study (CCHS, n = 10 391). Genetic variants which differed in frequency between the two extreme triglyceride groups (c.-1131T > C, S19W, and c.*31C > T; P-value: 0.06 to
AB - AimsElevated non-fasting triglycerides mark elevated levels of remnant cholesterol. Using a Mendelian randomization approach, we tested whether genetically increased remnant cholesterol in hypertriglyceridaemia due to genetic variation in the apolipoprotein A5 gene (APOA5) associates with an increased risk of myocardial infarction (MI).Methods and resultsWe resequenced the core promoter and coding regions of APOA5 in individuals with the lowest 1% (n = 95) and highest 2% (n = 190) triglyceride levels in the Copenhagen City Heart Study (CCHS, n = 10 391). Genetic variants which differed in frequency between the two extreme triglyceride groups (c.-1131T > C, S19W, and c.*31C > T; P-value: 0.06 to
U2 - 10.1093/eurheartj/ehs431
DO - 10.1093/eurheartj/ehs431
M3 - Journal article
C2 - 23248205
SN - 0195-668X
VL - 34
SP - 1826
EP - 1833
JO - Eur.Heart J.
JF - Eur.Heart J.
IS - 24
ER -